Xbrane And Biogen End Deal For Cimzia Biosimilar

Terminating Alliance On Certolizumab Pegol Will Set Back Xbrane’s Break-Even Goals

 
• By David Wallace
  
Photo of handshake ripped in half
Xbrane and Biogen have ended their alliance • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products